PHP
Parkman Healthcare Partners Portfolio holdings
AUM
$864M
This Quarter Return
+7.6%
1 Year Return
+33.7%
3 Year Return
+258.24%
5 Year Return
+878.92%
10 Year Return
–
AUM
$442M
AUM Growth
+$442M
(+12%)
Cap. Flow
+$48M
Cap. Flow
% of AUM
10.87%
Top 10 Holdings %
Top 10 Hldgs %
37.89%
Holding
92
New
17
Increased
38
Reduced
28
Closed
8
Top Buys
| 1 |
UnitedHealth
UNH
|
$19M |
| 2 |
CVS Health
CVS
|
$13.8M |
| 3 |
HCA Healthcare
HCA
|
$13M |
| 4 |
Danaher
DHR
|
$4.45M |
| 5 |
BioCryst Pharmaceuticals
BCRX
|
$4.13M |
Top Sells
| 1 |
Humana
HUM
|
$7.39M |
| 2 |
DexCom
DXCM
|
$6.74M |
| 3 |
Arcus Biosciences
RCUS
|
$4.84M |
| 4 |
CDMO
Avid Bioservices, Inc. Common Stock
CDMO
|
$4.67M |
| 5 |
Insulet
PODD
|
$4.61M |
Sector Composition
| 1 | Healthcare | 98.05% |
| 2 | Industrials | 1.73% |
| 3 | Technology | 0.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
IQVIA
IQV
$32.4B
| $20.6M | 4.55% | 73,112 +3,243 | +5% | +$915K |
|
2
United Therapeutics
UTHR
$13.8B
| $19.5M | 4.3% | 90,198 -4,126 | -4% | -$892K |
|
|
3
Danaher
DHR
$147B
| $19.4M | 4.27% | 58,847 +13,523 | +30% | +$4.45M |
|
|
4
UnitedHealth
UNH
$281B
| $19M | 4.19% | +37,823 | New | +$19M |
|
|
5
DexCom
DXCM
$29.5B
| $17.7M | 3.9% | 32,906 -12,552 | -28% | -$6.74M |
|
6
Avantor
AVTR
$9.18B
| $17.2M | 3.79% | 407,575 -32,425 | -7% | -$1.37M |
|
7
Aclaris Therapeutics
ACRS
$209M
| $14.9M | 3.29% | 1,025,522 -280,938 | -22% | -$4.08M |
|
|
8
CVS Health
CVS
$92.8B
| $13.8M | 3.04% | +133,334 | New | +$13.8M |
|
|
9
HCA Healthcare
HCA
$94.5B
| $13M | 2.87% | +50,661 | New | +$13M |
|
|
SGEN
10
DELISTED
Seagen Inc. Common Stock
SGEN
| $12.5M | 2.76% | 80,795 +8,119 | +11% | +$1.26M |
|
11
Natera
NTRA
$23.1B
| $11.6M | 2.57% | 124,550 +34,503 | +38% | +$3.22M |
|
12
Xenon Pharmaceuticals
XENE
$2.98B
| $11.3M | 2.49% | 360,502 +49,295 | +16% | +$1.54M |
|
|
HZNP
13
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $10.9M | 2.4% | 100,747 +20,980 | +26% | +$2.26M |
|
14
Codexis
CDXS
$246M
| $10.6M | 2.35% | 340,152 +54,085 | +19% | +$1.69M |
|
15
Cooper Companies
COO
$13.4B
| $9.94M | 2.19% | 23,715 -373 | -2% | -$156K |
|
16
Alnylam Pharmaceuticals
ALNY
$58.5B
| $9.78M | 2.16% | 57,682 -17,285 | -23% | -$2.93M |
|
17
Charles River Laboratories
CRL
$8.04B
| $9.76M | 2.15% | 25,901 +901 | +4% | +$339K |
|
18
Immunic
IMUX
$80.9M
| $9.32M | 2.06% | 974,183 +50,096 | +5% | +$479K |
|
|
CDMO
19
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $8.46M | 1.87% | 290,000 -160,000 | -36% | -$4.67M |
|
|
CTLT
20
DELISTED
CATALENT, INC.
CTLT
| $7.8M | 1.72% | 60,939 +21,200 | +53% | +$2.71M |
|
|
APEN
21
DELISTED
Apollo Endosurgery, Inc.
APEN
| $7.74M | 1.71% | 918,485 +87,271 | +10% | +$736K |
|
|
RCM
22
DELISTED
R1 RCM Inc. Common Stock
RCM
| $7.66M | 1.69% | 300,395 +155,395 | +107% | +$3.96M |
|
23
iRhythm Technologies
IRTC
$5.46B
| $7.29M | 1.61% | 61,980 +29,480 | +91% | +$3.47M |
|
24
Idexx Laboratories
IDXX
$51.8B
| $7.22M | 1.59% | 10,970 +3,303 | +43% | +$2.17M |
|
25
AbbVie
ABBV
$372B
| $7M | 1.55% | 51,722 -23,278 | -31% | -$3.15M |
|